Ledger.Open graph →
SEC Form D · filed November 19, 2020

Willow Biosciences Inc

Offering
$1.2M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CALGARY, Alberta, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Fotis H. Kalantzis · Calgary, Alberta, CanadaDirectorSadiq H. Lalani · Calgary, Alberta, CanadaDirectorAl Foreman · Tampa, FLDirectorPeter Seufer-Wasserthal · Calgary, Alberta, CanadaDirectorChristopher Speed · Calgary, Alberta, CanadaExecDonald H. Archibald · Calgary, Alberta, CanadaDirectorMathias Schuetz · Calgary, Alberta, CanadaExecJerry Ericsson · Calgary, Alberta, CanadaExecChris Savile · Calgary, Alberta, CanadaExecTravis Doupe · Calgary, Alberta, CanadaExecTrevor Peters · Calgary, Alberta, CanadaExec · DirectorTalkkari Troy · Calgary, Alberta, CanadaExecSadiq H. Lalani · Calgary, Alberta, CanadaDirectorFotis H. Kalantzis · Calgary, Alberta, CanadaDirectorAl Foreman · Tampa, FLDirectorPeter Seufer-Wasserthal · Calgary, Alberta, CanadaDirectorChristopher Speed · Calgary, Alberta, CanadaExecDonald H. Archibald · Calgary, Alberta, CanadaDirectorMathias Schuetz · Calgary, Alberta, CanadaExecJerry Ericsson · Calgary, Alberta, CanadaExecChris Savile · Calgary, Alberta, CanadaExecTravis Doupe · Calgary, Alberta, CanadaExecTrevor Peters · Calgary, Alberta, CanadaExec · DirectorTalkkari Troy · Calgary, Alberta, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗